Anti-third party CD8+ CTLs as potent veto cells:: Coexpression of CD8 and FasL is a prerequisite

被引:83
作者
Reich-Zeliger, S [1 ]
Zhao, Y [1 ]
Krauthgamer, R [1 ]
Bachar-Lustig, E [1 ]
Reisner, Y [1 ]
机构
[1] Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel
关键词
D O I
10.1016/S1074-7613(00)00050-9
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Several bone marrow cells and lymphocyte subpopulations, known as "veto cells," were shown to induce transplantation tolerance across major histocompatibility antigens. Recently, it has been suggested that anti-third party CTLs depleted of alloreactivity are endowed with marked veto activity and therefore might potentially facilitate bone marrow allografting without graft versus host disease (GVHD). The veto mechanism is still obscure. While early studies emphasized the role of CD8-mediated apoptosis, more recent evidence indicates a role for Fas-FasL. In the present study we show, by using blocking anti-CD8 antibody, by generating CTLs from FasL or perforin mutated mice, and by gene transfer of FasL, that the veto activity of anti-third party CD8(+) CTLs is dependent upon the simultaneous expression of both CD8 and FasL.
引用
收藏
页码:507 / 515
页数:9
相关论文
共 56 条
[1]   Immunoregulatory role of CD8α in the veto effect -: Transforming growth factor-β1 activation [J].
Asiedu, C ;
Meng, YR ;
Wang, W ;
Huang, Z ;
Contreras, JL ;
George, JF ;
Thomas, JM .
TRANSPLANTATION, 1999, 67 (03) :372-380
[2]   THRESHOLD TOLERANCE IN H-2K(B)-SPECIFIC TCR TRANSGENIC MICE EXPRESSING MUTANT H-2K(B) - CONVERSION OF HELPER-INDEPENDENT TO HELPER-DEPENDENT CTL [J].
AUPHAN, N ;
JEZOBREMOND, A ;
SCHONRICH, G ;
HAMMERLING, G ;
ARNOLD, B ;
MALISSEN, B ;
SCHMITTVERHULST, AM .
INTERNATIONAL IMMUNOLOGY, 1992, 4 (12) :1419-1428
[3]   SUCCESSFUL ENGRAFTMENT OF T-CELL-DEPLETED HAPLOIDENTICAL 3-LOCI INCOMPATIBLE TRANSPLANTS IN LEUKEMIA PATIENTS BY ADDITION OF RECOMBINANT HUMAN GRANULOCYTE-COLONY-STIMULATING FACTOR-MOBILIZED PERIPHERAL-BLOOD PROGENITOR CELLS TO BONE-MARROW INOCULUM [J].
AVERSA, F ;
TABILIO, A ;
TERENZI, A ;
VELARDI, A ;
FALZETTI, F ;
GIANNONI, C ;
IACUCCI, R ;
ZEI, T ;
MARTELLI, MP ;
GAMBELUNGHE, C ;
ROSSETTI, M ;
CAPUTO, P ;
LATINI, P ;
ARISTEI, C ;
RAYMONDI, C ;
REISNER, Y ;
MARTELLI, MF .
BLOOD, 1994, 84 (11) :3948-3955
[4]   Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype [J].
Aversa, F ;
Tabilio, A ;
Velardi, A ;
Cunningham, I ;
Terenzi, A ;
Falzetti, F ;
Ruggeri, L ;
Barbabietola, G ;
Aristei, C ;
Latini, P ;
Reisner, Y ;
Martelli, MF .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (17) :1186-1193
[5]   Induction of donor-type chimerism and transplantation tolerance across major histocompatibility barriers in sublethally irradiated mice by Sca-1+Lin- bone marrow progenitor cells:: Synergism with non-alloreactive (Host x Donor)F1 T cells [J].
Bachar-Lustig, E ;
Li, HW ;
Gur, H ;
Krauthgamer, R ;
Marcus, H ;
Reisner, Y .
BLOOD, 1999, 94 (09) :3212-3221
[6]   MEGADOSE OF T-CELL-DEPLETED BONE-MARROW OVERCOMES MHC BARRIERS IN SUBLETHALLY IRRADIATED MICE [J].
BACHARLUSTIG, E ;
RACHAMIM, N ;
LI, HW ;
LAN, FS ;
REISNER, Y .
NATURE MEDICINE, 1995, 1 (12) :1268-1273
[7]  
BACHERLUSTIG E, 2000, IN PRESS TRANSPLANT
[8]  
Bergenthal A, 1998, EUR J IMMUNOL, V28, P1911, DOI 10.1002/(SICI)1521-4141(199806)28:06<1911::AID-IMMU1911>3.0.CO
[9]  
2-N
[10]   The Fas-based mechanism of lymphocytotoxicity [J].
Berke, G .
HUMAN IMMUNOLOGY, 1997, 54 (01) :1-7